Losers Buzz: Goldman Sachs Group, Inc.(NYSE:GS), Potash Corp./Saskatchewan, Dynavax Technologies, Inovio Pharmaceuticals

Lakeway, NY -- (SBWIRE) -- 03/19/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Goldman Sachs Group, Inc.(NYSE:GS) shares decreased 1.87% and closed at $151.95. The company has poached Singapore-based institutional foreign exchange sales director Catherine Rich from Deutsche Bank (>> Deutsche Bank AG), people familiar with the matter said Tday. Ms. Rich, who is currently on gardening leave, will join Goldman's Sydney office as an executive director.

Is GS a Still a Buy after the Solid momentum? Let’s Find out Here

Potash Corp./Saskatchewan (USA) (NYSE:POT) shares fell 1.86% and closed at $40.13. The company, on Jan. 30, announced that it and its wholly owned subsidiary PCS Sales (USA) Inc. have settled eight private antitrust lawsuits, which were filed by direct and indirect purchasers of potash in the United States in U.S. federal courts in 2008, for a total of $43.75 million. The settlements are subject to final approval of the U.S. District Court for the Northern District of Illinois.

Is POT a Strong Buying Opportunity After The Recent Slump? Find out Here

Dynavax Technologies Corporation (NASDAQ:DVAX) shares fell 1.85% to $2.12. The company, on Feb. 25, announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA or Agency) regarding its Biologic License Application (BLA) for HEPLISAV, an investigational adult hepatitis B vaccine. In the CRL, the FDA specified that the indication in adults 18-70 years of age cannot be approved without further evaluation of safety in this broad age group.

Should DVAX Buy After The Recent Movement? Let’s Find out Here

Inovio Pharmaceuticals, Inc. (NYSEAMEX:INO) shares decreased 2.38% to $0.530. The company, on Mar. 12, announced that it has closed an underwritten offering of 27,377,266 shares of its common stock and warrants to purchase up to 13,688,633 shares of common stock at a combined price of $0.55 per share and related warrant for gross proceeds of $15.1 million. The warrants are exercisable at an exercise price of $.7936 per share and will expire, unless exercised, on the date that is 180 days after the fifth anniversary of the date of issuance.

Should INO Buy After The Recent Movement? Let’s Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.